Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Defining the mechanism by which niacin mediates its antiatherogenic properties

Jan. 3, 2002

Discovery of gene mutation that causes increased bone mass may lead to osteoporosis treatment

Jan. 2, 2002

Naturally produced PTP inhibitors in the Takeda pipeline

Jan. 2, 2002

Solid-phase synthesis and selection of dual PPARgamma/PPARdelta agonist

Jan. 2, 2002

Novel Roche compounds for type 2 diabetes

Jan. 2, 2002

Evidence that AGEs represent a treatment target for diabetic complications

Jan. 2, 2002

FDA approves insulin analogue for pump therapy

Dec. 31, 2001

Amylin anticipates filing NDA amendment for Symlin within the next six months

Dec. 28, 2001

Inhibition of PI3K enhances human sperm motility

Dec. 28, 2001

Lipase inhibitors produced by Streptomyces

Dec. 27, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...